First Horizon Corporation’s Boston Scientific BSX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
4,891
-3,703
-43% -$201K 0.01% 425
2026
Q1
$539K Buy
8,594
+266
+3% +$21.3K 0.02% 275
2025
Q4
$794K Buy
8,328
+2,487
+43% +$244K 0.04% 233
2025
Q3
$570K Buy
+5,841
New +$605K 0.03% 252
2021
Q2
$20K Buy
483
+9
+2% +$379 ﹤0.01% 545
2021
Q1
$18K Buy
474
+1
+0.2% +$38 ﹤0.01% 556
2020
Q4
$17K Buy
473
+37
+8% +$1.33K ﹤0.01% 539
2020
Q3
$16K Buy
+436
New +$16.8K ﹤0.01% 535

Other funds holding BSX

First Horizon Corporation's BSX Position: Q2 2026 in Review

First Horizon Corporation reduced its Boston Scientific (BSX) stake by 43% in Q2 2026, selling an estimated $201K and leaving 4,891 shares worth $209K. The position accounts for 0.01% of the portfolio, ranked #425.

First Horizon Corporation first reported a position in BSX in Q3 2020 and has held it in 8 quarters since. The position peaked at $794K in Q4 2025. 569 funds tracked by Wall St. Rank hold BSX as of Q2 2026.

  • First Horizon Corporation held 4,891 shares of Boston Scientific worth $209K as of Q2 2026.
  • First Horizon Corporation sold 3,703 Boston Scientific shares in Q2 2026, an estimated $201K.
  • Boston Scientific made up 0.01% of First Horizon Corporation's portfolio in Q2 2026, its #425 holding.
  • First Horizon Corporation first reported a position in Boston Scientific in Q3 2020 and has held it in 8 quarters since.
  • First Horizon Corporation's Boston Scientific position peaked at $794K in Q4 2025.
  • 569 funds tracked by Wall St. Rank held Boston Scientific as of Q2 2026.

Based on First Horizon Corporation's 13F filing for Q2 2026, filed 20 Jul 2026.